title: Radiotherapy: PSA nadir predicts long-term mortality.
abstract: The effect of PSA level on distant metastases and cause-specific mortality was assessed in a recent study, and showed a nadir PSA level 1.5 ng/ml within 2 years of radiotherapy treatment predicts distant metastases and death from prostate cancer.
authors.affiliation: Clinical Research, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111-2497, USA. mark.buyyounouski@fccc.edu
authors.forename: Mark K
authors.initials: MK
authors.lastname: Buyyounouski
mesh_terms: D014408:Biomarkers, Tumor; D018450:Disease Progression; D006801:Humans; D008297:Male; D011379:Prognosis; D017430:Prostate-Specific Antigen / Q000032:analysis* / Q000528:radiation effects; D011471:Prostatic Neoplasms / Q000401:mortality / Q000532:radiotherapy*; D011878:Radiotherapy; D012307:Risk Factors; D014481:United States
chemical_list: D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen